BALB/c and C57BL/6 mouse strains influence gastric function outcomes with administration of cisplatin and dexamethasone
Keywords:
BALB/c;, Bradygastria;, C57BL/6;, Gastric motility;, StomachAbstract
Our aim was to evaluate the effects of cisplatin and dexamethasone alone and combined on gastric contractility and histomorphometry of BALB/c and C57BL/6 mice. BALB/c and C57BL/6 male mice (8-week-old) were randomly separated into: Control; Cisplatin (7.5 mg/Kg); Dexamethasone (2.0 mg/Kg); and Dexamethasone plus Cisplatin (2.0 mg/Kg of dexamethasone 1-hour prior to 7.5 mg/Kg of cisplatin). Drugs were administered intraperitoneally for three days. Body weight and food intake were evaluated on 2nd day. Alternating Current Biosusceptometry technique was employed to measure gastric contractions on 3rd day. Afterward, mice were killed for gastric histomorphometric analysis. Cisplatin decreased food intake and caused bradygastria in BALB/c mice; however, the amplitude of gastric contractions decreased in both BALB/c and C57BL/6. Dexamethasone and cisplatin combined restored the gastric frequency and food intake only in BALB/c, but drug combination reduced the gastric amplitude of contractions in both strains. Dexamethasone alone increased gastric mucosa thickness in C57BL/6 and decreased muscular thickness in BALB/c. In conclusion, the mouse strains presented differences in acute effects of cisplatin and dexamethasone alone and combined on gastric function. This reinforces the importance of choosing the appropriate mouse strain for studying the acute effects of drugs on the gastrointestinal tract.
Downloads
References
Américo MF, Marques RG, Zandoná EA, Andreis U, Stelzer M, Corá LA, et al. Validation of ACB in vitro and in vivo as a biomagnetic method for measuring stomach contraction. Neurogastroenterol Motil. 2010;22(12):1340-e374.
Aston WJ, Hope DE, Nowak AK, Robinson BW, Lake RA, Lesterhuis WJ. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17(1):1-10.
Cabezos PA, Vera G, Castillo M, Fernández-Pujol R, Martín MI, Abalo R. Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci. 2008;141(1-2):54-65.
Camilleri M, Linden DR. Measurement of gastrointestinal and colonic motor functions in humans and animals. Cell Mol Gastroenterol Hepatol. 2016;2(4):412-28.
Clements PJ, Bolon B, McInnes E, Mukaratirwa S, Scudamore C. Animal Models in Toxicologic Research: Rodents, Haschek WM, Rousseaux CG, Wallig AM, Bolon B, Haschek and Rousseaux’s Handbook of Toxicologic Pathology (Fourth Edition). Academic Press. 2021,653-94.
Corá LA, Romeiro FG, Stelzer M, Américo M, Oliveira RB, Baffa O, et al. AC Biosusceptometry in the study of drug delivery. Adv Drug Deliv Rev. 2005;57(8):1223-41.
Gama LA, Machado MPR, Beckmann APS, Miranda JRA, Corá LA, Américo MF. Gastrointestinal motility and morphology in mice: Strain‐dependent differences. Neurogastroenterol Motil . 2020;32(6):e13824.
Gong D, Zhao H, Liang Y, Chao R, Chen L, Yang S, et al. Differences in cocaine-and morphine-induced cognitive impairments and serum corticosterone between C57BL/6J and BALB/cJ mice. Pharmacol Biochem Behav. 2019;182:1-6.
Gong YL, Liu F, Jin H, Xu L, Guo FF. Involvement of ghrelin in nucleus tractus solitaries on gastric signal afferent and gastric motility in cisplatin-treated rats. Eur Rev Med Pharmacol Sci. 2016;20(16):3480-89.
Gosselin T, Le Guisquet AM, Brizard B, Hommet C, Minier F, Belzung C. Fluoxetine induces paradoxical effects in C57BL6/J mice: comparison with BALB/c mice. Behav Pharmacol. 2017;28(6):466-476.
Guo F, Xu L, Gao S, Sun X, Zhang N, Gong Y. Effect of orexin-A in the arcuate nucleus on cisplatin-induced gastric side effects in rats. Neurosci Res. 2019;143:53-60.
Holland RA, Leonard JJ, Kensey NA, Hannikainen PA, De Jonghe BC. Cisplatin induces neuronal activation and increases central AMPA and NMDA receptor subunit gene expression in mice. Physiol Behav. 2014;136:79-85.
Izbeki F, Asuzu DT, Lorincz A, Bardskey MR, Popko LN, Choi KN, et al. Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice. J Physiol. 2010;588(16):3101-17.
Jin T, Jiang Z, Luan X, Qu Z, Guo F, Gao S, et al. Exogenous orexin-a microinjected into central nucleus of the amygdala modulates feeding and gastric motility in rats. Front Neurosci. 2020;14:274.
Keane T, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477(7364):289-94.
Kornel L, Prancan AV, Kanamarlapudi N, Hynes J, Kuzianik E. Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo. Endocr Res. 1995;21(1-2):203-210.
Liu Y, Zhang S, Ye F, Yin J, Li S, Chen JD. Ameliorating effects and mechanisms of chronic electroacupuncture at ST36 in a rodent model of dyspepsia induced by cisplatin. Neurogastroenterol Motil . 2018;31(1):e13474.
Liu YL, Malik N, Sanger GJ, Friedman MI, Andrews PL. Pica - a model of nausea? Species differences in response to cisplatin. Physiol Behav . 2005;85(3):271-7.
Lu CL, Chen CY, Luo JC, Chang FY, Lee SD, Wu HC, et al. Impaired gastric myoelectricity in patients with chronic pancreatitis: Role of maldigestion. World J Gastroenterol. 2005;11(3):372-6.
Malik NM, Liu YL, Cole N, Sanger GJ, Andrews PL. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol. 2007;555(2-3):164-73.
Marques RG, Américo MF, Spadella CT, Corá LA, Oliveira RB, Miranda JRA. Different patterns between mechanical and electrical activities: an approach to investigate gastric motility in a model of long-term diabetic rats. Physiol Meas. 2014;35(1):69-81.
Melgar S, Karlsson A, Michaëlsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;288(6):G1328-38.
Miller KE, Bajzer Ž, Hein SS, Phillips JE, Syed S, Wright AM, et al. High temporal resolution gastric emptying breath tests in mice. Neurogastroenterol Motil. 2018;30(8):e13333.
Natale JJ. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Hosp Pract (1995). 2015;43(4):226-34.
Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374(14):1356-67.
Obara Y, Machida T, Takano Y, Shiga A, Suzuzi A, Hamaue N, et al. Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(8):847-858.
Perše M. Cisplatin mouse models: treatment, toxicity and translatability. Biomedicines. 2021;9(10):1406.
Pini A, Garella R, Idrizaj E, Calosi L, Baccari MC, Vannucchi MG. Glucagon‐like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. Neurogastroenterol Motil. 2016;28(2):206-16.
Plata-Salamán CR. Dexamethasone inhibits food intake suppression induced by low doses of interleukin-1 β administered intracerebroventricularly. Brain Res Bull. 1991;27(5):737-8.
Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol. 2019;32(8):1469-86.
Rudd JA, Yamamoto K, Yamatodani A, Takeda N. Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption (“pica”) in rats. Eur J Pharmacol . 2002;454(1):47-52.
Sanger GJ, Broad J, Andrews PL. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments. Eur J Pharmacol . 2013;715(1-3):10-4.
Sankoorikal GM, Kaercher KA, Boon CJ, Lee JK, Brodkin ES. A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol Psychiatry. 2006;59(5):415-23.
Shahid F, Farooqui Z, Khan F. Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies. Eur J Pharmacol . 2018;827:49-57.
Soni KG, Halder T, Conner ME, Preidis GA. Sexual dimorphism in upper gastrointestinal motility is dependent on duration of fast, time of day, age, and strain of mice. Neurogastroenterol Motil . 2019;31(9):e13654.
Uranga JA, García‐Martínez JM, García‐Jiménez C, Vera G, Martín‐Fontelles MI, Abalo R. Alterations in the small intestinal wall and motor function after repeated cisplatin in rat. Neurogastroenterol Motil . 2017;29(7):e13047.
Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer. 2006;94(7):1011-5.
Viana-Cardoso KV, da Silva MT, Palheta Júnior RC, Peixoto Junior AA, Pinho LG, Santos AA, et al. Repeated cisplatin treatments inhibit gastrointestinal motility and induces baroreflex changes and mechanical hyperalgesia in rats. Cancer Invest. 2011;29(7):494-500.
Yamamoto K, Okui R, Yamatodani A. Effects of a histamine H4 receptor antagonist on cisplatin-induced anorexia in mice. Neurosci Lett. 2018;676:103-107.
Yamamoto K, Yamatodani A. Strain differences in the development of cisplatin-induced pica behavior in mice. J Pharmacol Toxicol Methods. 2018;91:66-71.
Yang CK, Wu CE, Liaw CC. Combination of palonosetron, aprepitant, and dexamethasone as primary antiemetic prophylaxis for cisplatin-based chemotherapy. Biomed J. 2016;39(1):60-6.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Funding data
-
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Grant numbers 001
